Search Results - "Sun, Duxin"
-
1
Why 90% of clinical drug development fails and how to improve it?
Published in Acta pharmaceutica Sinica. B (01-07-2022)“…Ninety percent of clinical drug development fails despite implementation of many successful strategies, which raised the question whether certain aspects in…”
Get full text
Journal Article -
2
Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer
Published in Cell metabolism (03-07-2018)“…Myeloid-derived suppressor cells (MDSCs) inhibit anti-tumor immunity. Aerobic glycolysis is a hallmark of cancer. However, the link between MDSCs and…”
Get full text
Journal Article -
3
Microbial Metabolite Signaling Is Required for Systemic Iron Homeostasis
Published in Cell metabolism (07-01-2020)“…Iron is a central micronutrient needed by all living organisms. Competition for iron in the intestinal tract is essential for the maintenance of indigenous…”
Get full text
Journal Article -
4
Discovery of QCA570 as an Exceptionally Potent and Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of the Bromodomain and Extra-Terminal (BET) Proteins Capable of Inducing Complete and Durable Tumor Regression
Published in Journal of medicinal chemistry (09-08-2018)“…Proteins of the bromodomain and extra-terminal (BET) family are epigenetics “readers” and promising therapeutic targets for cancer and other human diseases. We…”
Get full text
Journal Article -
5
Structure-Based Discovery of SD-36 as a Potent, Selective, and Efficacious PROTAC Degrader of STAT3 Protein
Published in Journal of medicinal chemistry (26-12-2019)“…Signal transducer and activator of transcription 3 (STAT3) is a transcription factor and an attractive therapeutic target for cancer and other human diseases…”
Get full text
Journal Article -
6
Tumor-derived exosomes: Nanovesicles made by cancer cells to promote cancer metastasis
Published in Acta pharmaceutica Sinica. B (01-08-2021)“…Nanomedicine usually refers to nanoparticles that deliver the functional drugs and siRNAs to treat cancer. Recent research has suggested that cancer cells can…”
Get full text
Journal Article -
7
Multiparameter Optimization of Oxidative Phosphorylation Inhibitors for the Treatment of Pancreatic Cancer
Published in Journal of medicinal chemistry (24-02-2022)“…Targeting oxidative phosphorylation (OXPHOS) complexes is an emerging strategy to disrupt the metabolism of select cancer subtypes and to overcome resistance…”
Get full text
Journal Article -
8
Targeted Degradation of BET Proteins in Triple-Negative Breast Cancer
Published in Cancer research (Chicago, Ill.) (01-05-2017)“…Triple-negative breast cancers (TNBC) remain clinically challenging with a lack of options for targeted therapy. In this study, we report the development of a…”
Get full text
Journal Article -
9
Discovery and Lead Optimization of Benzene-1,4-disulfonamides as Oxidative Phosphorylation Inhibitors
Published in Journal of medicinal chemistry (13-01-2022)“…Inhibition of oxidative phosphorylation (OXPHOS) is a promising therapeutic strategy for select cancers that are dependent on aerobic metabolism. Here, we…”
Get full text
Journal Article -
10
Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome
Published in Science translational medicine (02-12-2020)“…Nonalcoholic fatty liver disease (NAFLD) including nonalcoholic steatohepatitis (NASH) has reached epidemic proportions with no pharmacological therapy…”
Get more information
Journal Article -
11
A Potent Small-Molecule Inhibitor of the MDM2–p53 Interaction (MI-888) Achieved Complete and Durable Tumor Regression in Mice
Published in Journal of medicinal chemistry (11-07-2013)“…We previously reported the discovery of a class of spirooxindoles as potent and selective small-molecule inhibitors of the MDM2–p53 interaction (MDM2…”
Get full text
Journal Article -
12
ASGARD is A Single-cell Guided Pipeline to Aid Repurposing of Drugs
Published in Nature communications (22-02-2023)“…Single-cell RNA sequencing technology has enabled in-depth analysis of intercellular heterogeneity in various diseases. However, its full potential for…”
Get full text
Journal Article -
13
Sulforaphane, a Dietary Component of Broccoli/Broccoli Sprouts, Inhibits Breast Cancer Stem Cells
Published in Clinical cancer research (01-05-2010)“…The existence of cancer stem cells (CSCs) in breast cancer has profound implications for cancer prevention. In this study, we evaluated sulforaphane, a natural…”
Get full text
Journal Article -
14
Sulforaphane Enhances the Anticancer Activity of Taxanes against Triple Negative Breast Cancer by Killing Cancer Stem Cells
Published in Cancer letters (28-05-2017)“…Abstract Triple negative breast cancer (TNBC) typically exhibits rapid progression, high mortality and faster relapse rates relative to other breast cancer…”
Get full text
Journal Article -
15
Pharmacologic Inhibition of the Menin-MLL Interaction Blocks Progression of MLL Leukemia In Vivo
Published in Cancer cell (13-04-2015)“…Chromosomal translocations affecting mixed lineage leukemia gene (MLL) result in acute leukemias resistant to therapy. The leukemogenic activity of MLL fusion…”
Get full text
Journal Article -
16
Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycin
Published in Oncogene (01-04-2020)“…TP53 mutation in acute myeloid leukemia (AML) is associated with poor prognosis. Since no targeted therapy is available to restore p53 function, it is of great…”
Get full text
Journal Article -
17
Discovery of first-in-class inhibitors of ASH1L histone methyltransferase with anti-leukemic activity
Published in Nature communications (14-05-2021)“…ASH1L histone methyltransferase plays a crucial role in the pathogenesis of different diseases, including acute leukemia. While ASH1L represents an attractive…”
Get full text
Journal Article -
18
Characterization of Celastrol to Inhibit Hsp90 and Cdc37 Interaction
Published in The Journal of biological chemistry (18-12-2009)“…The molecular chaperone heat shock protein 90 (Hsp90) is required for the stabilization and conformational maturation of various oncogenic proteins in cancer…”
Get full text
Journal Article -
19
Engineering exosomes as refined biological nanoplatforms for drug delivery
Published in Acta pharmacologica Sinica (01-06-2017)Get full text
Journal Article -
20
A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivo
Published in Molecular cancer therapeutics (01-03-2014)“…Using a high-throughput screening (HTS) approach, we have identified and validated several small-molecule Mcl-1 inhibitors (SMI). Here, we describe a novel…”
Get full text
Journal Article